|
시장보고서
상품코드
1964374
임상 품질 관리 시스템(CQMS) 시장 규모, 점유율, 성장 분석 : 구성요소별, 도입 형태별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Clinical Quality Management System (CQMS) Market Size, Share, and Growth Analysis, By Component (Software, Services), By Deployment Mode (Cloud-Based CQMS, On-Premises), By Application, By End-User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 임상 품질 관리 시스템(CQMS) 시장 규모는 2024년에 18억 달러로 평가되었으며, 2025년 19억 9,000만 달러에서 2033년까지 44억 2,000만 달러로 성장할 전망입니다. 예측 기간(2026-2033년) 동안 CAGR은 10.5%로 예측됩니다.
세계 임상 품질 관리 시스템(CQMS) 시장은 제약사, CRO(임상시험수탁기관), 의료기기 제조업체의 중앙집중식 품질 관리의 필요성이 증가하면서 점점 더 큰 성장을 하고 있습니다. 규제가 복잡해지고 환자 안전이 최우선 과제로 떠오르면서 수작업에 의한 품질 프로세스에 대한 의존도가 낮아지고 디지털 솔루션으로의 전환이 가속화되고 있습니다. 주요 요인으로는 규제 당국의 감시 강화와 검사 대응이 가능한 프로세스를 요구하는 리스크 기반 프레임워크의 도입이 꼽힙니다. 종이 기록에서 클라우드 네이티브 및 분석 기능을 갖춘 시스템으로의 전환은 이러한 진화를 상징합니다. AI는 문서 검토의 자동화와 워크플로우의 효율화를 통해 컴플라이언스 효율성을 높이고, 관리 부담을 줄여 시험 프로세스를 가속화합니다. 모듈형 AI 지원 SaaS 솔루션을 제공하는 벤더들은 새로운 시장 기회를 활용할 준비가 되어 있으며, CQMS 시장의 추가 성장을 촉진할 것으로 보입니다.
세계 임상 품질 관리 시스템(CQMS) 시장 촉진요인
전 세계적으로 규제 기준이 점점 더 복잡해지고 엄격해지면서 생명과학 기업들은 일관된 규정 준수, 문서화 프로세스 강화, 임상시험 전반에 걸친 원활한 모니터링을 위해 강력한 임상 품질 관리 시스템(CQMS)을 도입해야 하는 상황에 직면해 있습니다. CQMS 플랫폼은 표준화된 절차, 중앙 집중식 데이터 관리, 감사 대응 태세를 제공하여 조직 리스크를 크게 줄이고 규제 당국과의 커뮤니케이션을 지원합니다. 스폰서, CRO(임상시험수탁기관) 및 임상시험 기관이 규제 요건을 충족할 뿐만 아니라 업무 효율성과 우수한 거버넌스 관행을 촉진하는 시스템을 점점 더 많이 요구함에 따라, 명확한 품질 및 추적성에 대한 필요성이 통합 CQMS 솔루션에 대한 투자를 촉진하고 있습니다. 투자하고 있습니다.
세계 임상 품질 관리 시스템(CQMS) 시장의 억제요인
세계 시장에서 종합적인 임상 품질 관리 시스템(CQMS)의 도입은 몇 가지 도전과제에 가로막혀 있습니다. 소규모 스폰서나 CRO는 도입, 커스터마이징, 통합에 따른 막대한 비용에 직면하는 경우가 많으며, 이는 플랫폼에 대한 투자를 망설이게 하는 요인으로 작용합니다. 리소스 제약으로 인해 시스템 설정, 적절한 벤더 선정, 내부 프로세스 재설계가 어려워지는 한편, 지속적인 유지보수 및 업그레이드의 필요성이 재정적 부담을 가중시킵니다. 또한, CQMS를 기존 임상 및 기업 시스템과 통합할 때 발생하는 복잡성은 의사결정을 지연시키거나 덜 종합적인 대안을 선택할 수 있어 시장 성장을 더욱 제한할 수 있습니다.
세계 임상 품질 관리 시스템(CQMS) 시장 동향
세계 임상 품질 관리 시스템(CQMS) 시장에서는 고급 기계 학습과 자연어 처리를 통합한 AI 기반 품질 인텔리전스(AI-driven quality intelligence)로의 전환이 두드러지게 나타나고 있습니다. 이러한 진화를 통해 품질 위험의 사전 식별을 촉진하고 임상 업무 및 품질 보증의 모니터링을 자동화할 수 있습니다. 이러한 시스템은 다양한 데이터 소스를 통합하여 인사이트를 맥락화하여 중요한 이슈의 우선순위를 정하고, 수동 검토의 작업량을 줄이고 의사결정 프로세스를 강화합니다. 이러한 전환은 기존의 사후적인 컴플라이언스 점검에서 지속적인 품질 모니터링 및 시정 조치 계획으로의 전환을 촉진하고, 궁극적으로 일관성을 강화하여 품질 팀이 개발 주기 전반에 걸쳐 전략적 리스크 관리와 부서 간 협업에 집중할 수 있도록 지원합니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 임상 품질 관리 시스템(CQMS) 시장 규모 : 구성요소별 & CAGR(2026-2033년)
세계의 임상 품질 관리 시스템(CQMS) 시장 규모 : 전개 방식별 & CAGR(2026-2033년)
세계의 임상 품질 관리 시스템(CQMS) 시장 규모 : 용도별 & CAGR(2026-2033년)
세계의 임상 품질 관리 시스템(CQMS) 시장 규모 : 최종사용자별 & CAGR(2026-2033년)
세계의 임상 품질 관리 시스템(CQMS) 시장 규모 & CAGR(2026-2033년)
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.03.23Global Clinical Quality Management System (Cqms) Market size was valued at USD 1.8 Billion in 2024 and is poised to grow from USD 1.99 Billion in 2025 to USD 4.42 Billion by 2033, growing at a CAGR of 10.5% during the forecast period (2026-2033).
The Global Clinical Quality Management System (CQMS) market is increasingly driven by the need for centralized quality management in pharmaceutical companies, contract research organizations, and medical device manufacturers. As regulatory complexity escalates and patient safety becomes a priority, reliance on manual quality processes is diminishing, prompting the shift toward digital solutions. Key factors include heightened regulatory scrutiny and the implementation of risk-based frameworks that demand inspection-ready processes. The transition from paper records to cloud-native and analytics-enabled systems exemplifies this evolution. AI is enhancing compliance efficiency by automating document reviews and streamlining workflows, thereby reducing the administrative burden and expediting trial processes. Vendors providing modular, AI-enabled SaaS solutions are poised to capitalize on emerging market opportunities, further driving the CQMS market forward.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Quality Management System (Cqms) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Clinical Quality Management System (Cqms) Market Segments Analysis
Global clinical quality management system (cqms) market is segmented by component, deployment mode, application, end-user and region. Based on component, the market is segmented into Software and Services. Based on deployment mode, the market is segmented into Cloud-Based CQMS and On-Premises. Based on application, the market is segmented into Clinical Document Management, Quality Assurance, Risk Management, Regulatory Compliance Management, Clinical Audit Management and Others. Based on end-user, the market is segmented into Clinical Document Management, Quality Assurance, Risk Management, Regulatory Compliance Management, Clinical Audit Management and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Clinical Quality Management System (Cqms) Market
The rising intricacy and strictness of worldwide regulatory standards drive life sciences organizations to implement robust clinical quality management systems (CQMS) to maintain consistent compliance, enhance documentation processes, and facilitate oversight throughout clinical trials. CQMS platforms provide standardized procedures, centralized data management, and readiness for audits, significantly lowering organizational risk and aiding in regulatory communications. The necessity for evident quality and traceability fosters investment in cohesive CQMS solutions, as sponsors, contract research organizations, and clinical sites increasingly seek systems that not only align with regulatory demands but also promote operational efficiency and good governance practices.
Restraints in the Global Clinical Quality Management System (Cqms) Market
The adoption of comprehensive Clinical Quality Management Systems (CQMS) in the global market is hindered by several challenges. Smaller sponsors and contract research organizations often encounter significant costs associated with implementation, customization, and integration, which may discourage them from investing in these platforms. Resource limitations can impede their ability to configure systems, select appropriate vendors, and redesign internal processes, while the ongoing need for maintenance and upgrades adds to their financial burden. Additionally, the complexity involved in integrating CQMS with existing clinical and enterprise systems can lead to delayed decision-making or a preference for less comprehensive alternatives, further restricting market growth.
Market Trends of the Global Clinical Quality Management System (Cqms) Market
The Global Clinical Quality Management System (CQMS) market is witnessing a notable trend towards AI-driven quality intelligence, characterized by the integration of advanced machine learning and natural language processing. This evolution facilitates proactive identification of quality risks and automates oversight within clinical operations and quality assurance. By synthesizing diverse data sources, these systems contextualize insights to prioritize significant issues, thereby diminishing manual review workloads and enhancing decision-making processes. This shift promotes a transition from traditional retrospective compliance checks to continuous quality monitoring and corrective action planning, ultimately bolstering consistency and empowering quality teams to concentrate on strategic risk management and cross-functional collaboration throughout development cycles.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Clinical Quality Management System (CQMS) Market Size by Component & CAGR (2026-2033)
- Market Overview
- Software
- Quality Management Software
- Document Management
- Audit Management
- Risk Management
- Training Management
- Others
- Services
- Implementation Services
- Consulting Services
- Support & Maintenance
- Others
Global Clinical Quality Management System (CQMS) Market Size by Deployment Mode & CAGR (2026-2033)
- Market Overview
- Cloud-Based CQMS
- On-Premises
Global Clinical Quality Management System (CQMS) Market Size by Application & CAGR (2026-2033)
- Market Overview
- Clinical Document Management
- Quality Assurance
- Risk Management
- Regulatory Compliance Management
- Clinical Audit Management
- Others
Global Clinical Quality Management System (CQMS) Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Clinical Document Management
- Quality Assurance
- Risk Management
- Regulatory Compliance Management
- Clinical Audit Management
- Others
Global Clinical Quality Management System (CQMS) Market Size & CAGR (2026-2033)
- North America (Component, Deployment Mode, Application, End-User)
- US
- Canada
- Europe (Component, Deployment Mode, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Component, Deployment Mode, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Component, Deployment Mode, Application, End-User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Component, Deployment Mode, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Medidata Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Veeva Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oracle Health Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IBM Watson Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Syntactx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quality Clinical Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Perceptive Informatics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Covance
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eclinicalhealth
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioclinica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TrialInteractive
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Clinipace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medpace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Celerion
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Parexel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ArisGlobal
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OmniComm Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cenduit
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CRF Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- eClinicalWorks
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
